AMP Capital Investors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-120,252
Closed -$21.2M 1268
2020
Q1
$21.2M Buy
120,252
+10,352
+9% +$1.95M 0.16% 157
2019
Q4
$20.9M Buy
109,900
+179
+0.2% +$32.3K 0.11% 210
2019
Q3
$18.5M Sell
109,721
-10,671
-9% -$1.74M 0.1% 231
2019
Q2
$20M Sell
120,392
-17,368
-13% -$2.4M 0.11% 211
2019
Q1
$20.2M Sell
137,760
-4,569
-3% -$662K 0.11% 211
2018
Q4
$18.9M Buy
142,329
+24,205
+20% +$3.97M 0.12% 196
2018
Q3
$22.5M Buy
118,124
+18,786
+19% +$3.45M 0.12% 203
2018
Q2
$16.6M Buy
99,338
+8,125
+9% +$1.3M 0.09% 250
2018
Q1
$15.1M Buy
91,213
+2,085
+2% +$350K 0.09% 269
2017
Q4
$14.6M Sell
89,128
-4,841
-5% -$869K 0.08% 283
2017
Q3
$19.3M Sell
93,969
-18,478
-16% -$4.3M 0.11% 214
2017
Q2
$27.4M Sell
112,447
-19,823
-15% -$4.66M 0.16% 150
2017
Q1
$31.7M Buy
132,270
+2,270
+2% +$529K 0.19% 127
2016
Q4
$26.9M Sell
130,000
-10,113
-7% -$2.09M 0.16% 139
2016
Q3
$32.3M Sell
140,113
-20,665
-13% -$5.05M 0.2% 115
2016
Q2
$37.1M Sell
160,778
-2,318
-1% -$534K 0.25% 94
2016
Q1
$44.8M Buy
163,096
+7,588
+5% +$2.17M 0.3% 78
2015
Q4
$49M Sell
155,508
-680
-0.4% -$202K 0.33% 72
2015
Q3
$39.4M Sell
156,188
-16,183
-9% -$4.97M 0.29% 82
2015
Q2
$51.6M Buy
172,371
+9,176
+6% +$2.74M 0.33% 79
2015
Q1
$49.7M Buy
163,195
+34,853
+27% +$9.94M 0.3% 84
2014
Q4
$33.3M Sell
128,342
-13,252
-9% -$3.31M 0.2% 124
2014
Q3
$34.6M Buy
141,594
+41,963
+42% +$9.39M 0.22% 113
2014
Q2
$22.2M Buy
99,631
+4,918
+5% +$1.02M 0.14% 187
2014
Q1
$19.3M Buy
94,713
+11,259
+13% +$2.23M 0.13% 203
2013
Q4
$13.8M Buy
83,454
+40,532
+94% +$6.34M 0.1% 256
2013
Q3
$6.19M Sell
42,922
-31,847
-43% -$4.24M 0.05% 430
2013
Q2
$9.41M Buy
+74,769
New +$8.47M 0.07% 305

Other funds holding AGN

AMP Capital Investors's AGN Position: Q2 2020 in Review

AMP Capital Investors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 120,252 shares — an estimated $21.2M sold.

AMP Capital Investors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $51.6M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AMP Capital Investors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AMP Capital Investors sold 120,252 Allergan plc shares in Q2 2020, an estimated $21.2M.
  • AMP Capital Investors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • AMP Capital Investors's Allergan plc position peaked at $51.6M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AMP Capital Investors's 13F filing for Q2 2020, filed 14 Aug 2020.